Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity

Journal: Nature Communications

Published: 2020-01-07

DOI: 10.1038/s41467-019-13972-y

Affiliations: 7

Authors: 23

Go to article
Institutions Share
OHSU Division of Pathobiology and Immunology, United States of America (USA) 0.38
NIH NIAID Vaccine Research Center (VRC), United States of America (USA) 0.22
Oregon National Primate Research Center (ONPRC), United States of America (USA) 0.17
OHSU Division of Comparative Medicine (DCM), United States of America (USA) 0.09
OHSU Department of Molecular Microbiology and Immunology (MMI), United States of America (USA) 0.08
OHSU Vaccine and Gene Therapy Institute (VGTI), United States of America (USA) 0.06

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER